Sulfadiazine Powder

Sulfadiazine Powder - High-Purity Pharmaceutical Grade API

Xi'an Linnas Biotech Co., Ltd. manufactures pharmaceutical-grade Sulfadiazine Powder fulfilling strict international pharmacopeial standards, such as USP, EP, and BP requirements, with a minimum purity of 99%. This white crystalline sulfonamide antibiotic (C10H10N4O2S, MW 250.28) is clinically superior for treating meningococcal meningitis and cerebral toxoplasmosis due to its remarkable cerebrospinal fluid penetration capabilities. Our production facility has extensive quality control measures and operates under ISO 9001 accreditation. Every batch is subjected to stringent HPLC assay verification, keeps drying loss under 0.5%, and guaranties that the heavy metal content complies with ICH safety regulations. Delivery is completed within three days of payment confirmation and is offered in drums of 20 kilogram, 25 kg, and 50 kg. Samples are available upon request.

Technical Specifications and Quality Parameters

Mechanism of Action and Pharmaceutical Advantages

Sulfadiazine Powder functions as a competitive inhibitor of bacterial dihydropteroate synthase, effectively blocking folic acid synthesis pathways essential for DNA replication. Broad-spectrum activity against both gram-positive and gram-negative pathogens is provided by this bacteriostatic mechanism.

The substance exhibits delayed renal excretion kinetics and quick gastric absorption. This pharmacokinetic profile lowers the frequency of doses needed for your formulations by sustaining therapeutic blood concentrations over long periods of time.

This API reaches therapeutically meaningful quantities in cerebral fluid, in contrast to traditional sulfonamides. It is crucial in neurological infection treatment procedures where alternative antibiotics exhibit poor CNS distribution due to its exceptional blood-brain barrier penetration capacity.

Primary Industrial Applications

Manufacturing of Veterinary Pharmaceuticals

This API is an essential active ingredient used in the production of veterinary medicines to treat bacterial pneumonia in cattle and coccidiosis in poultry. It produces synergistic formulations with trimethoprim that stop the emergence of resistance in large-scale animal husbandry operations.

Its demonstrated effectiveness in challenging agricultural settings benefits your veterinary product lines. Boluses, injectables, and feed additives for aquatic and poultry applications are among the dosage forms that the compound's stability profile enables.

Synthesis of Silver Sulfadiazine

Our ultrahigh purity powder, which serves as the main reactant for the synthesis of silver sulfadiazine, guaranties the best possible reaction stability during the complexation of silver nitrate. Because the final topical product is the gold standard for burn treatment globally, this application requires very high quality criteria.

This grade is used by pharmaceutical companies to make broad-spectrum antibacterial lotions. By offering vital protection against Pseudomonas aeruginosa in necrotic tissue settings, these formulations help severe burn sufferers avoid sepsis.

Clinical Formulations with Specialization

This API is used by clinical compounding pharmacies to make tablets and oral suspensions that target Toxoplasma encephalitis in patients with impaired immune systems. When traditional antibiotics show insufficient CNS activity, its blood-brain barrier penetration resolves therapy issues.

Formulations that take advantage of this distinctive distribution feature give your specialty medicine portfolio a competitive edge. The substance works well for infections of the central nervous system that call for long-term therapeutic concentrations in cerebrospinal fluid.

Quality Control and Inspection Standards

When assessing suppliers, procurement teams should give priority to a number of important quality measures. Minimum 99.0% purity levels are confirmed by HPLC test verification, guaranteeing uniform therapeutic efficacy throughout production batches.

In order to avoid hydrolytic deterioration during storage and transportation, loss on drying tests results must be less than 0.5%. The stability profile and shelf life of your product are directly impacted by this parameter.

Sulfanilamide and degradation byproducts that jeopardize pharmaceutical quality are identified by related compounds analysis. In order to comply with the strict ICH criteria for safety and efficacy, our production procedure minimizes these contaminants.

Whether you need conventional grades for tablet compression or micronized powder for suspensions, particle size distribution testing guaranties formulation compatibility. The absence of inorganic impurities introduced during synthesis is confirmed by heavy metal screening and residue on ignition tests.

Storage and Handling Recommendations

Containers should be kept dry, cold, and out of direct sunlight. Pharmaceutical quality may be compromised by the compound's photosensitivity and delayed darkening in response to UV light.

To stop moisture absorption, keep storage conditions airtight. Because it is practically insoluble in water but soluble in bases and acids, choosing the right container helps avoid unwanted reactions with ambient humidity.

To guaranty the best possible product freshness, use first-in, first-out inventory rotation. Even tho the chemical exhibits exceptional stability under the right circumstances, moisture management and light protection are crucial throughout the supply chain.

Frequently Asked Questions

Q: What pharmacopeial requirements does your powdered sulfadiazine meet?

A: With a purity of 99.0–100.5% determined on a dried basis, our product satisfies USP, EP, and BP requirements. For every batch shipping, we offer Certificates of Analysis attesting to conformity.

Q: Is it possible for you to offer supporting material for regulatory submissions?

A: In order to support your regulatory filings in foreign countries, we do provide Drug Master Files (DMF), manufacturing process descriptions, and thorough quality documentation.

Q: What lead times and minimum order quantities are applicable?

A: Orders up to 20 kg drums are accepted, and delivery is finished within three days of payment confirmation. Prior to bulk acquisition, samples are available for qualification testing.

Q: What role does your product play in preventing resistance in veterinary applications?

A: A key industry problem is addressed when the chemical is combined with trimethoprim to create synergistic combinations that dramatically minimize the development of bacterial resistance in large-scale agricultural settings.

Q: What distinguishes various suppliers in terms of quality?

A: Particle size consistency, photostability, and the content of related chemicals are important differentiators. The batch-to-batch consistency required for controlled pharmaceutical production is guarantyd by our ISO 9001-certified manufacturing.

Partner With a Trusted API Manufacturer

Our technical team provides formulation consultation and regulatory documentation assistance throughout your Sulfadiazine Powder development cycle.Contact us at cathy@linnas.com.cn to request samples, technical datasheets, or discuss your specific pharmaceutical ingredient requirements.